Evidence map›Paper›PMID 32015123›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

High-throughput quantitative microscopy-based half-life measurements of intravenously injected agents.

Laura G Bracaglia, Alexandra S Piotrowski-Daspit, Chun-Yu Lin, Zoe M Moscato, Yongheng Wang, Gregory T Tietjen, W Mark Saltzman

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Engineered cargo-free nanoparticle decoys for phagocytic modulation of macrophages.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Rational nanoparticle design: Optimization using insights from experiments and mathematical models.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Review
  12. Article
  13. Article
  14. Polymeric vehicles for nucleic acid delivery.Advanced drug delivery reviews · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Laura G BracagliaDepartment of Biomedical Engineering, Yale University, New Haven, CT 06511.
Alexandra S Piotrowski-DaspitDepartment of Biomedical Engineering, Yale University, New Haven, CT 06511.
Chun-Yu LinDepartment of Biomedical Engineering, Yale University, New Haven, CT 06511.
Zoe M MoscatoDepartment of Biomedical Engineering, Yale University, New Haven, CT 06511.
Yongheng WangDepartment of Biomedical Engineering, Yale University, New Haven, CT 06511.
Gregory T TietjenDepartment of Biomedical Engineering, Yale University, New Haven, CT 06511.
W Mark SaltzmanDepartment of Biomedical Engineering, Yale University, New Haven, CT 06511; mark.saltzman@yale.edu.
Yale University · US

Funding

PATHOPHYSIOLOGY OF ACUTE AND CHRONIC RENAL DISEASET32DK007276 · NIDDK · YALE UNIVERSITY · PI ARONSON, PETER S., CANTLEY, LLOYD G · 1986 to 2022
$9.3M
Research Training in AnesthesiaT32GM086287 · NIGMS · YALE UNIVERSITY · PI ROBERT SCHONBERGER · 2009 to 2026
$3.7M
Poly(amine-co-ester)s for Targeted Delivery In Vivo of Gene Editing Agents to Bone Marrow and LungUG3HL147352 · NHLBI · YALE UNIVERSITY · PI GLAZER, PETER M, SALTZMAN, W. MARK · 2018 to 2020
$2.4M
Poly(amine-co-ester)s for targeted delivery of gene editing agents to treat cystic fibrosis in animal models: SCGE Disease Models Studies SupplementUH3HL147352 · NHLBI · YALE UNIVERSITY · PI GLAZER, PETER M, SALTZMAN, W. MARK · 2021 to 2022
$2.4M
Targeted correction of the human CFTR geneR01HL125892 · NHLBI · YALE UNIVERSITY · PI EGAN, MARIE E, GLAZER, PETER M · 2015 to 2018
$2.2M
Ex Vivo Nanoparticle Drug Delivery Targeted to Human Renal Allograft EndotheliumU01AI132895 · NIAID · YALE UNIVERSITY · PI POBER, JORDAN S, SALTZMAN, W. MARK · 2017 to 2021
$2.2M
Yale Interdisciplinary Bioengineering Training Grant for Diabetes ResearchT32DK101019 · NIDDK · YALE UNIVERSITY · PI SALTZMAN, W. MARK · 2013 to 2017
$1.5M
Developing Poly(amine-co-ester) Polymeric Delivery Vehicles and 3D Culture Screening Platforms for the Treatment of Hereditary Beta-thalassemia with Peptide Nucleic Acid Genome Editing TechnologyF32HL142144 · NHLBI · YALE UNIVERSITY · PI PIOTROWSKI-DASPIT, ALEXANDRA SARAH ANNUKKA · 2018 to 2019
$123k
NHLBI NIH HHS F32 HL142144NHLBI NIH HHS R01 HL125892NHLBI NIH HHS UG3 HL147352NHLBI NIH HHS UH3 HL147352NIAID NIH HHS U01 AI132895NIDDK NIH HHS T32 DK007276NIDDK NIH HHS T32 DK101019NIGMS NIH HHS T32 GM086287
6 · The paper itself

Abstract

Accurate analysis of blood concentration and circulation half-life is an important consideration for any intravenously administered agent in preclinical development or for therapeutic application. However, the currently available tools to measure these parameters are laborious, expensive, and inefficient for handling multiple samples from complex multivariable experiments. Here we describe a robust high-throughput quantitative microscopy-based method to measure the blood concentration and circulation half-life of any fluorescently labeled agent using only a small (2 µL) amount of blood volume, enabling additional end-point measurements to be assessed in the same subject. To validate this method, we demonstrate its use to measure the circulation half-life in mice of two types of fluorescently labeled polymeric nanoparticles of different sizes and surface chemistries and of a much smaller fluorescently labeled monoclonal antibody. Furthermore, we demonstrate the improved accuracy of this method compared to previously described methods.

Indexed as

AnimalsDrug MonitoringFemaleHalf-LifeHigh-Throughput Screening AssaysHumansInjections, IntravenousMaleMiceMice, Inbred BALB CMicroscopyNanoparticlesPharmaceutical PreparationsPharmaceutical Preparationscirculation half-lifedrug deliverynanoparticlequantitative microscopy

Identifiers

PMID32015123
PMCPMC7035491
OpenAlexW3004719946

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.